EXACT Therapeutics - Notice for Annual General Meeting 2026

OSLO, May 29 2026: The Annual General Meeting of EXACT Therapeutics AS (“EXACT-Tx”, Euronext Growth: EXTX), will be held as a virtual meeting at 10:30 CEST on June 12, 2026.

The formal notice of the Annual General Meeting is attached and provides further information on the proceedings. The documents are also available at www.exact-tx.com.

For more information, please contact:

Per Walday, CEO EXACT Therapeutics Email per.walday@exact-tx.com

John M. Edminson, CFO EXACT Therapeutics Email: john.edminson@exact-tx.com

About EXACT Therapeutics: EXACT Therapeutics is a clinical-stage precision medicine company utilizing the power of ultrasound to activate the proprietary drug PS101 and enhance the clinical benefit of oncology therapies. PS101 has a unique mode of action and may be combined with a wide range of therapeutic agents within oncology and across a multitude of other indications, including brain diseases. EXACT Therapeutics’ shares are traded on Euronext Growth Oslo (EXTX). Further information may be found here: www.exact-tx.com